If you're too busy to keep monitoring your stock portfolio every other day, then investing in stocks that won't cause you a ...

By aiding weight loss, Zepbound can improve symptoms of obstructive sleep apnea (OSA) in people with obesity — but CPAP ...

Although Novo will still make a mind-blowing amount of money from its existing obesity drugs in the coming years (its ...

In a new study, an experimental obesity drug from Novo Nordisk called CagriSema allowed people to lose more than 20% of their ...

Unless the government intervenes to lower the price or forces insurers to cover the drugs, they will remain out of range for ...

As the year draws to a close, Wall Street is set to crown Eli Lilly (NYSE:LLY) among the best in Big Pharma, while Novo ...

Alzheimer's, addiction, cardiovascular diseases, kidney disorders, sleep apnoea, diabetes, obesity, and overweight.

The fight against obstructive sleep apnea (OSA) has taken a monumental leap forward. For the first time, the U.S. Food and ...

Since the start of 2020, Eli Lilly’s (NYSE: LLY) stock price chart has been straight up and to the right, up 500.39% and ...

The FDA has declared an end to the shortage of a popular obesity drug. The implications for consumers are complicated.

Airports are warning of delays for both departing and arriving flights as thick fog continues around the country. Director-General of the World Health Organization, Tedros Adhanom Ghebreyesus ...

From cocktails to Christmas cookies, Malaika Arora's December was equal parts cosy and glamorous Take a look at some of the most interesting online food delivery orders across India that stole the ...